Automation is no longer just about efficiency – it’s about enabling new ways of working, accelerating discovery, and demonstrating value to both scientists and the business. This panel will bring together leaders who are piloting, scaling, and embedding automation into their labs to explore what’s working, what’s next, and how to overcome the cultural and technical barriers that remain.
Discussion points:
Join this session to learn:
Join this session to discuss:
Implementing AI and digital transformation in laboratory environments often faces resistance due to established practices and workflows. This session presents proven strategies to overcome these challenges, ensuring successful adoption and long-term success.
Non-standardised data generation and capture workflows often hinder efforts to apply machine learning in small molecule optimization. In this case study, Daniel Baeschlin shares how Novartis is systematically addressing these challenges to enable more consistent, machine-readable lab data.
Attendees will gain insights into:
As labs generate ever-growing volumes of data across discovery, development, clinical, and commercial functions, the challenge has shifted from collecting data to connecting it. In this keynote, Michael will share a pragmatic roadmap—drawing on real-world experience with Microsoft Fabric, Scitara, and leading informatics platforms—to build a truly connected lab that enables scalability, interoperability, and AI-readiness without adding technical debt.
Key takeaways:
In today’s rapidly evolving lab environment, adopting new technologies is only part of the challenge—demonstrating their value to leadership is just as critical. This keynote will guide you through how to articulate the impact of your technology initiatives in a way that resonates with decision-makers.